Clinical Trial Update: Liposomal Bupivacaine Use in Alveolar Bone Graft Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating liposomal bupivacaine for pain management in alveolar bone graft patients with cleft lip and palate; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cleft Lip and Palate

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Kerry O'Rourke | Conditions: Cleft Lip and Palate | Phase 3 | Status: RECRUITING